Memorandum of Understanding

In April 2016, the Medicines Patent Pool (MPP) and the TB Alliance signed a Memorandum of Understanding to encourage the development of new tuberculosis (TB) regimens and ensure their availability in low- and middle-income countries. The two organisations are working together on a range of initiatives with a focus on public health-oriented licensing strategies and the sharing of intellectual property to spur research and development of affordable new TB treatments. 


This page is also available in: French, Spanish